The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab

Author： Kornacker M   Verneris MR   Kornacker B   Ganten TM   Scheffold C   Negrin RS  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.8, Iss.1, 2006-02, pp. : 13-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

By Li Hui   Wang Changli   Yu Jinpu   Cao Shui   Wei Feng   Zhang Weihong   Han Ying   Ren Xiu-bao  

Cytotherapy, Vol. 11, Iss. 8, 2009-11 ,pp. : 1076-1083

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells

By Rettinger Eva   KuçI Selim   Naumann Ivonne   Becker Petra   Kreyenberg Hermann   Anzaghe Martina   Willasch Andre   Koehl Ulrike   Bug Gesine   Ruthardt Martin   Klingebiel Thomas   Fulda Simone   Bader Peter  

Cytotherapy, Vol. 14, Iss. 1, 2012-01 ,pp. : 91-103

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol

By Rutella Sergio   Iudicone Paola   Bonanno Giuseppina   Fioravanti Daniela   Procoli Annabella   Lavorino Claudio   Foddai Maria Laura   Lorusso Domenica   Martinelli Enrica   Vacca Michele   Ipsevich Francesco   Nuti Marianna   Scambia Giovanni   Pierelli Luca  

Cytotherapy, Vol. 14, Iss. 7, 2012-08 ,pp. : 841-850

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysis

By Ma Yue   Zhang Zan   Tang Lei   Xu Ying-Chun   Xie Zhi-Ming   Gu Xiao-Feng   Wang Hong-Xia  

Cytotherapy, Vol. 14, Iss. 4, 2012-04 ,pp. : 483-493

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission

By Linn Yeh-Ching   Yong Hao-Xiang   Niam Madelaine   Lim Tsyr-Jong   Chu Sixian   Choong Alicia   Chuah Charles   Goh Yeow-Tee   Hwang William   Loh Yvonne   Ng Heng-Joo   Suck Garnet   Chan Marieta   Koh Mickey  

Cytotherapy, Vol. 14, Iss. 7, 2012-08 ,pp. : 851-859

Ashgate Publishing Ltd

Access to resources Recommend Favorite